The FDA puts impossibly high safety requirements on weight loss drugs that make it a nightmare to develop new treatments. Weight loss drugs have to have no side effects in any patients at any time. While a theoretical target (yes it is on my list), until the FDA starts taking obesity seriously and weighing the risk/reward balance, it is not a development path any rational biotech should pursue.
Pillar 1 - FTO (new thread), page-39
-
- There are more pages in this discussion • 2,901 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
-0.155(7.67%) |
Mkt cap ! $338.8M | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.08 | $1.86 | $706.9K | 357.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2637 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 577 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |